the issue price is $0.157 for all shares applied for before closing date. the amount of shares finally issued to an investor is subject to scale back. I'm yet to determine whether I'll participate in the SPP. I did sell out my entire holding the other day @ 30cps for a modest profit after a couple of years in the red - obviously the SPP would be an overwhelming success if the SP remained anywhere near that level. However, this company does frequently disappoint . Given the current SP I expect your application will not be scaled back - but who knows? Anyway, good luck.
- Forums
- ASX - By Stock
- Ann: Acrux Receives FDA Approval - Generic Testosterone Solution
ACR
acrux limited
Add to My Watchlist
5.00%
!
1.9¢

the issue price is $0.157 for all shares applied for before...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $13.72K | 687.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 10000 | 1 |
0.021 | 177000 | 1 |
0.022 | 27574 | 2 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 14.19pm 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online